Resources Sichenzia Ross Friedman Ference LLP Represents BioPharmX Corporation in $930,000 Registered Direct Offering May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents General Cannabis Corp. in $2.6 million Private Offering of Senior Secured Notes and Warrants May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents SITO MOBILE, Ltd. in $11.5 Million Public Offering May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $5 Million Registered Direct Offering May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Aridis Pharmaceuticals in $15 Million Private Placement May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $3.77 Registered Direct Offering May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Vuzix Corporation in $6.6 Million Public Offering May 6, 2020 Read More › Partners Marc J. Ross and James M. Turner Represent Tonix Pharmaceuticals in $10 Million Public Offering of Common Stock May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar in $2.1 Million Public Offering of Intellicheck Mobilisa, Inc. May 6, 2020 Read More › Partners Richard A. Friedman and Stephen A. Cohen Represent Laidlaw & Company (UK) Ltd. and Roth Capital Partners, LLC as Joint Book Running Managers of PhaseRx, Inc.’s $18.5M IPO May 6, 2020 Read More › Partners Marc Ross and James Turner Represent Taglich Brothers, Inc. in a $1.355 Million Private Placement May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Axiom Capital Management, Inc. In $1.2 Million Public Offering of iSign Solutions Inc. May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar and Fordham Financial Management in $7.5 Million Public Offering of Aytu Bioscience, Inc. May 6, 2020 Read More › Partner Jeffrey Fessler Represents Synergy Pharmaceuticals Inc. on $89.8 Million Registered Direct Offering of Common Stock May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents DelMar Pharmaceuticals, Inc. in $7.5 Million Sale of Series B Preferred Shares May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Citius Pharmaceuticals Inc. in connection with its acquisition of LM Biosciences, Inc. May 6, 2020 Read More › Partner Jeffrey Fessler Represents ContraVir Pharmaceuticals, Inc. on $7.0 Million Public Offering of Common Stock and Warrants May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents H.C. Wainwright & Co., LLC and Joseph Gunnar & Co., LLC as Joint Book Running Managers for $6.0 Public Offering and Uplisting to Nasdaq May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Viatar CTC Solutions Inc. in a $4.2 Million Private Placement May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $6.9 Million Private Placement May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in a $3 Million Registered Direct Offering May 6, 2020 Read More › « Previous 1 … 42 43 44 45 46 … 82 Next »
